česky | english | sitemap

Czech Gynaecological and Obstetrical Society | Ministry of Health | Faculty of Medicine, Masaryk University |       Institute of Biostatistics and Analyses, Masaryk University
GlaxoSmithKline     Roche |

Other sources of information
Cervical cytology (in Czech)www.cipek.cz
Cervical cytology
Cancer Screening in the European Unionec.europa.eu
Cancer Screening in the European Union (2017)
[ 10,6 MB]
SVOD - Epidemiology of malignant tumours in the Czech Republicwww.svod.cz
Epidemiology of malignant tumours
in the Czech Republic
NCI Bethesda System
HPV College




Year: 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008

Studies reveal potential of HPV vaccine to substantially reduce incidence of cervical cancer and suggest screening programmes could be modified
9.11.2011 ecancermedicalscience | More information...

The bivalent human papillomavirus (HPV) vaccine (Cervarix, GlaxoSmithKline) offers excellent protection against the more serious immediate precursor to invasive cervical cancer (ICC), particularly when given to young adolescent girls before they become sexually active. The findings of two studies published in The Lancet Oncology, also show that the vaccine partially protects against four other cancer-causing HPV types not targeted by the formulation, that together with HPV16/18, cause about 85% of cervical cancer worldwide.

First global analysis of breast and cervical cancer estimates 2 million new cases worldwide
15.9.2011 ecancermedicalscience | More information...

The number of new cases of breast cancer diagnosed worldwide has risen dramatically from about 640 000 in 1980 to 1.6 million in 2010. During the same period, cervical cancer incidence and death rates have been decreasing, but the disease still killed 200 000 women in 2010, according to the first global estimates published in The Lancet.

Contraceptive intrauterine devices could reduce risk of cervical cancer
13.9.2011 Cancer Research UK | More information...

Contraceptive intrauterine devices (IUDs) could substantially reduce the risk of women developing cervical cancer, new research from Spain shows.

HIV drug lopinavir 'may prevent cervical cancer' by targeting the virus that causes the disease
5.5.2011 Cancer Research UK | More information...

A commonly used HIV treatment could prevent cases of cervical cancer by killing off cells infected with the human papillomavirus (HPV), according to a new laboratory study.